References
- Gopal S, Patel MR, Yanik EL, et al. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer I. 2013;105:1221–1229.
- Moir S, Fauci AS. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Immunol Rev. 2013;254:207–224.
- Bibas M. Polyclonal serum free light chains: a biomarker of disease prognosis or of immune senescence? J Clin Oncol. 2012;30:3033–3034.
- Maurer MJ, Micallef INM, Cerhan JR, et al. Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma. J Clin Oncol. 2011;29:1620–1626.
- Thompson CA, Maurer MJ, Cerhan JR, et al. Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma. Am J Hematol. 2011;86:998–1000.
- Jardin F, Delfau-Larue MH, Molina TJ, et al. Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma. 2013;54:1898–1907.
- Landgren O, Goedert JJ, Rabkin CS, et al. Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol. 2010;28:773–779.
- Bibas M, Trotta MP, Cozzi-Lepri A, et al. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. Am J Hematol. 2012;87:749–753.
- Bibas M, Lorenzini P, Cozzi-Lepri A, et al. Polyclonal serum-free light chains elevation in HIV-infected patients. AIDS. 2012;26:2107–2110.
- Shiels MS, Landgren O, Costello R, et al. Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis. 2012;55:e103–e108.
- Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Sem Cancer Biol. 2014;26:99–115.
- Gloghini A, Dolcetti R, Carbone A. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin Cancer Biol. 2013;23:457–467.
- Navarro JT, Hernández A, Rodríguez-Manzano J, et al. Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients. Med Clin (Barc). 2010;135:485–490.
- Kanakry JA, Li H, Gellert LL, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 2013;121:3547–3553.